CHRO Michel Voigt bought 2,250 shares as stock trades well below 52-week highs; prior track record shows one poorly-timed sale.
Michel Voigt, the Chief Human Resources Officer of Merit Medical, made a substantial open-market purchase of shares at a time when the stock has declined meaningfully from its highs and fallen over a recent three-month window. The company itself remains solidly profitable with solid revenue growth, suggesting the operational fundamentals have not deteriorated despite the recent pullback. Voigt's prior track record includes one sale that preceded further gains in the stock, indicating he has not demonstrated strong timing on exits in this company. This buy represents his first open-market purchase on record—adding to zero prior buys—which makes the purchase notable as a reversal of his prior activity pattern. While a CHO's view may carry less weight than a CEO or CFO would, a C-suite executive buying during a downturn when holding no prior conviction buys could signal belief that the stock's recent weakness is overdone relative to the company's profitable operations.